324 related articles for article (PubMed ID: 33205239)
1. Selective retina therapy (SRT) in patients with therapy refractory persistent acute central serous chorioretinopathy (CSC): 3 months functional and morphological results.
Büttner M; Luger B; Abou Moulig W; Junker B; Framme C; Jacobsen C; Knoll K; Pielen A;
Graefes Arch Clin Exp Ophthalmol; 2021 Jun; 259(6):1401-1410. PubMed ID: 33205239
[TBL] [Abstract][Full Text] [Related]
2. Selective Retina Therapy in Acute and Chronic-Recurrent Central Serous Chorioretinopathy.
Framme C; Walter A; Berger L; Prahs P; Alt C; Theisen-Kunde D; Kowal J; Brinkmann R
Ophthalmologica; 2015; 234(4):177-88. PubMed ID: 26368551
[TBL] [Abstract][Full Text] [Related]
3. Selective retina therapy with automatic real-time feedback-controlled dosimetry for chronic central serous chorioretinopathy in Korean patients.
Park YG; Kang S; Kim M; Yoo N; Roh YJ
Graefes Arch Clin Exp Ophthalmol; 2017 Jul; 255(7):1375-1383. PubMed ID: 28421342
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the Safety and Efficacy of Selective Retina Therapy Laser Treatment in Patients with Central Serous Chorioretinopathy.
Oh J; Yoon CK; Kim BH; Yu HG
Korean J Ophthalmol; 2021 Feb; 35(1):51-63. PubMed ID: 33307626
[TBL] [Abstract][Full Text] [Related]
5. The Effect of Selective Retina Therapy for Bevacizumab-Resistant Chronic Central Serous Chorioretinopathy.
Jeon SH; Kim M; Lee J; Roh YJ
Ophthalmologica; 2022; 245(1):91-100. PubMed ID: 34649253
[TBL] [Abstract][Full Text] [Related]
6. Half-dose photodynamic therapy followed by diode micropulse laser therapy as treatment for chronic central serous chorioretinopathy: evaluation of a prospective treatment protocol.
Breukink MB; Mohr JK; Ossewaarde-van Norel A; den Hollander AI; Keunen JE; Hoyng CB; Boon CJ
Acta Ophthalmol; 2016 Mar; 94(2):187-97. PubMed ID: 26670630
[TBL] [Abstract][Full Text] [Related]
7. Retinal sensitivity after selective retina therapy (SRT) on patients with central serous chorioretinopathy.
Yasui A; Yamamoto M; Hirayama K; Shiraki K; Theisen-Kunde D; Brinkmann R; Miura Y; Kohno T
Graefes Arch Clin Exp Ophthalmol; 2017 Feb; 255(2):243-254. PubMed ID: 27497611
[TBL] [Abstract][Full Text] [Related]
8. Selective Retina Therapy in Patients With Chronic Central Serous Chorioretinopathy: A Pilot Study.
Kang S; Park YG; Kim JR; Seifert E; Theisen-Kunde D; Brinkmann R; Roh YJ
Medicine (Baltimore); 2016 Jan; 95(3):e2524. PubMed ID: 26817895
[TBL] [Abstract][Full Text] [Related]
9. Central Serous Chorioretinopathy: Morphological and Functional Outcome after Subthreshold Thermal Laser Coagulation with a Frequency-Doubled Nd:YAG Continuous-Wave Laser.
Enders C; Lang GE; Mayer B; Werner JU
Ophthalmologica; 2022; 245(1):59-68. PubMed ID: 34517369
[TBL] [Abstract][Full Text] [Related]
10. Impairment of visual acuity and retinal morphology following resolved chronic central serous chorioretinopathy.
Gawęcki M; Jaszczuk-Maciejewska A; Jurska-Jaśko A; Kneba M; Grzybowski A
BMC Ophthalmol; 2019 Jul; 19(1):160. PubMed ID: 31345183
[TBL] [Abstract][Full Text] [Related]
11. Clinical experience with eplerenone to treat chronic central serous chorioretinopathy.
Cakir B; Fischer F; Ehlken C; Bühler A; Stahl A; Schlunck G; Böhringer D; Agostini H; Lange C
Graefes Arch Clin Exp Ophthalmol; 2016 Nov; 254(11):2151-2157. PubMed ID: 27145785
[TBL] [Abstract][Full Text] [Related]
12. Comparison between the outcomes of fluorescein angiography-guided and indocyanine green angiography-guided half-time photodynamic therapy for central serous chorioretinopathy.
Hayashida M; Miki A; Honda S; Nakamura M
Photodiagnosis Photodyn Ther; 2020 Sep; 31():101955. PubMed ID: 32818640
[TBL] [Abstract][Full Text] [Related]
13. [Selective retina therapy in central serous chorioretinopathy with detachment of the pigmentary epithelium].
Klatt C; Elsner H; Pörksen E; Brinkmann R; Bunse A; Birngruber R; Roider J
Ophthalmologe; 2006 Oct; 103(10):850-5. PubMed ID: 16937094
[TBL] [Abstract][Full Text] [Related]
14. Clinical evaluation of neovascular and non-neovascular chronic central serous chorioretinopathy (CSC) diagnosed by swept source optical coherence tomography angiography (SS OCTA).
Sulzbacher F; Schütze C; Burgmüller M; Vécsei-Marlovits PV; Weingessel B
Graefes Arch Clin Exp Ophthalmol; 2019 Aug; 257(8):1581-1590. PubMed ID: 31037488
[TBL] [Abstract][Full Text] [Related]
15. Clinical characteristics of chronic central serous chorioretinopathy patients with insufficient response to reduced-settings photodynamic therapy.
van Rijssen TJ; van Dijk EHC; Dijkman G; Boon CJF
Graefes Arch Clin Exp Ophthalmol; 2018 Aug; 256(8):1395-1402. PubMed ID: 29732468
[TBL] [Abstract][Full Text] [Related]
16. Morphologic changes in acute central serous chorioretinopathy evaluated by fourier-domain optical coherence tomography.
Fujimoto H; Gomi F; Wakabayashi T; Sawa M; Tsujikawa M; Tano Y
Ophthalmology; 2008 Sep; 115(9):1494-500, 1500.e1-2. PubMed ID: 18394706
[TBL] [Abstract][Full Text] [Related]
17. Selective retina therapy in patients with central serous chorioretinopathy.
Elsner H; Pörksen E; Klatt C; Bunse A; Theisen-Kunde D; Brinkmann R; Birngruber R; Laqua H; Roider J
Graefes Arch Clin Exp Ophthalmol; 2006 Dec; 244(12):1638-45. PubMed ID: 16758179
[TBL] [Abstract][Full Text] [Related]
18. [Observation on long-term efficacy of half-dose photodynamic therapy with chronic central serous chorioretinopathy using optical coherence tomography].
Liu Y; Li L; Xu G; Wang W
Zhonghua Yan Ke Za Zhi; 2016 May; 52(5):328-34. PubMed ID: 27220704
[TBL] [Abstract][Full Text] [Related]
19. Half-Fluence Photodynamic Therapy for Chronic Central Serous Chorioretinopathy: Predisposing Factors for Visual Acuity Outcomes.
Matušková V; Vysloužilová D; Uher M
Semin Ophthalmol; 2018; 33(5):690-699. PubMed ID: 29252091
[TBL] [Abstract][Full Text] [Related]
20. Factors Predicting Response to Selective Retina Therapy in Patients with Chronic Central Serous Chorioretinopathy.
Kim M; Jeon SH; Lee JY; Lee SH; Roh YJ
J Clin Med; 2022 Jan; 11(2):. PubMed ID: 35054017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
